The Impact of Infection Control Policies on Hospital Acquired Infections by MDROs from 2016 to 2023
Yichen Wang,Yibo Zhang,Qun Wang,Wenhui Li,Dake Shi,Yumin Xu
DOI: https://doi.org/10.2147/idr.s481412
2024-09-29
Infection and Drug Resistance
Abstract:Yichen Wang, 1, &ast Yibo Zhang, 1, &ast Qun Wang, 1 Wenhui Li, 1 Dake Shi, 1 Yumin Xu 1, 2 1 Department of Hospital Infection Management, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China; 2 Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yumin Xu, Email Purpose: Hospital-acquired infections (HAIs) caused by multidrug-resistant organisms (MDROs) pose a significant challenge to healthcare systems. The present study aimed to evaluate the impact of the infection policy to COVID-19 on the incidence of HAIs caused by MDROs. Methods: We conducted an eight-years retrospective analysis at a hospital in Shanghai, China. Bloodstream, sputum, and urinary tract cultures of MDROs obtained 48h after admission were collected monthly from January 2016 to Dec 2023. Occupied bed days (OBDs) were used to generate monthly HAI incidences per 10,000 OBDs. The study period was divided into pre-control, in-control, and post-control cohorts, in January 2020 and January 2022. The incidence was compared using interrupted time-series regression. Results: In total, 6763 MDRO cultures were identified, comprising 1058 bloodstream, 4581 sputum, and 1124 urine cultures derived from 4549 patients. The incidence rates of all HAIs were 8.68 per 10,000 OBDs in the pre-control cohort, 9.76 per 10,000 OBDs in the in-control cohort and 12.58 per 10,000 OBDs in the post-control cohorts, respectively. A downward trend in the incidence of HAI was observed in the post-control cohort (p< 0.05). Conclusion: This study demonstrates that while the COVID-19 pandemic poses a significant challenge to infection control within hospitals, it provides a unique opportunity to enhance infection control measures and evaluate their effectiveness. In addition, these findings highlight the need for more targeted prevention and control strategies against different pathogens in future epidemics. Keywords: hospital required infection, multidrug-resistant organism, infection control, policy, Covid-19, surveillance Hospital-acquired infections (HAIs), also known as nosocomial infections, are infections occurring in patients 48 h after admission or upon discharge. HAIs lead to adverse outcomes such as prolonged hospitalization, increased healthcare expenses, and elevated mortality rates. 1 Multidrug-resistant bacteria (MDRO) pose a significant threat in this context. ESKAPE, a group of bacteria capable of evading antibiotic action, has emerged within hospital settings, with Enterobacter spp, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii , and Pseudomonas aeruginosa identified as the most critical by the World Health Organization (WHO). 2 The COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. However, its impact on global antimicrobial resistance and associated HAIs remains unclear, and is likely to vary across different populations and disease hotspots. 3–5 Countries with relatively lax infection control policies, such as the US and Italy, may experience more severe repercussions of antimicrobial resistance and HAIs. 6,7 However, certain changes in human behavior and healthcare practices prompted by the pandemic, such as enhanced infection control measures and improved hygiene, may have mitigated the impact of COVID on HAIs. 8 The Chinese government has implemented a "dynamic zero-clearance" policy based on national circumstances, continuously reinforcing prevention and control measures to avert large-scale pandemic resurgences, 9 which reduces the incidence of HAIs, though further research on drug-resistant bacteria is warranted. 10 In December 2022, following the issuance of the "New 10 Guidelines", which means reopening measures, China experienced an initial wave of infection peaks. This study evaluates the impact of the infection control policy of COVID-19 on HAIs caused by MDROs. This retrospective single-center study involved an eight-year analysis of inpatient laboratory data. Data were sourced from a teaching hospital affiliated with Shanghai Jiao Tong University School of Medicine, with a total of 2300 beds, between January 2016 and December 2023. We constructed three cohorts: the pre-control cohort was defined as inpatients who had their specimens collected between January 2016 and December 2019. Second, the in-control cohort comprised inpatients with specimens collected between January 2020 and -Abstract Truncated-
pharmacology & pharmacy,infectious diseases